Your browser doesn't support javascript.
loading
Comparative study between efficacy of Excimer light with topical Tacrolimus 0.1% versus excimer light with topical Bimatoprost 0.01% in treatment of facial Vitiligo.
Zaky, Mohamed S; Atallah, Rabie B; El Abasy, Nada Taha Ali; Elsaie, Mohamed L.
Afiliación
  • Zaky MS; Department of Dermatology, Venereology and Andrology, Damietta Faculty of Medicine, Al-Azhar University, Damietta, Egypt.
  • Atallah RB; Department of Dermatology, Venereology and Andrology, Damietta Faculty of Medicine, Al-Azhar University, Damietta, Egypt.
  • El Abasy NTA; Department of Dermatology, Damietta Dermatology and Leprosy Hospital, Damietta, Egypt.
  • Elsaie ML; Department of Dermatology, Medical Research and Clinical Studies Institute, National Research Centre, Giza, Egypt. Egydoc77@yahoo.com.
Arch Dermatol Res ; 316(7): 350, 2024 Jun 08.
Article en En | MEDLINE | ID: mdl-38850408
ABSTRACT
Loss and absence of melanocytes due to a number of factors is responsible for vitiligo; known to be the commonest disorder of pigmentation. The aim of the current work was to compare the efficacy and safety of excimer light with topical tacrolimus ointment 0.1% versus excimer light with topical bimatoprost gel 0.01% in treatment of facial vitiligo. The study was carried out on 48 patients presented with facial vitiligo. The patients were divided randomly using sealed envelope method into two groups (24 patients each). Group 1 were treated with excimer light plus topical tacrolimus ointment 0.1% and group 2 treated with excimer light plus topical bimatoprost gel 0.01%. Clinical improvement based on the quartile grading scale at the end of treatment did not show any statistically significant difference between groups. The majority of subjects in both groups experienced good to excellent improvement. Only 20.9% of patients in group 1 and 33.3% of subjects in group 2 achieved less than 50% repigmentation (p = 0.889). Our study demonstrated that 0.01% topical bimatoprost gel in combination with excimer light is considered safe and effective as treatment of nonsegmental facial vitiligo with comparable results to 0.1% tacrolimus.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vitíligo / Tacrolimus / Bimatoprost Límite: Adolescent / Adult / Child / Female / Humans / Male / Middle aged Idioma: En Revista: Arch Dermatol Res Año: 2024 Tipo del documento: Article País de afiliación: Egipto

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vitíligo / Tacrolimus / Bimatoprost Límite: Adolescent / Adult / Child / Female / Humans / Male / Middle aged Idioma: En Revista: Arch Dermatol Res Año: 2024 Tipo del documento: Article País de afiliación: Egipto
...